84 related articles for article (PubMed ID: 6398791)
1. [Immunology of malignant ovarian tumors. I. Familial occurrence, antigens and specific immunity].
Markowska J
Ginekol Pol; 1984 Sep; 55(9):695-700. PubMed ID: 6398791
[No Abstract] [Full Text] [Related]
2. Cell-mediated immune reaction to two gynecologic malignant tumors.
DiSala PJ; Rutledge FN; Smith JP; Sinkovics JG
Cancer; 1971 Nov; 28(5):1129-37. PubMed ID: 5125661
[No Abstract] [Full Text] [Related]
3. Detection of malignant ovarian neoplasms: a review of the literature. III. Immunological detection and ovarian cancer-associated antigens.
Smith LH; Oi RH
Obstet Gynecol Surv; 1984 Jun; 39(6):346-60. PubMed ID: 6203071
[TBL] [Abstract][Full Text] [Related]
4. [Immunologic aspects of ovarian tumors].
Makarov OV; Khashchukoeva AZ; Borisenko SA; Epeĭkina TN; Moiseeva NB
Akush Ginekol (Mosk); 1988 Nov; (11):3-6. PubMed ID: 3071162
[No Abstract] [Full Text] [Related]
5. On the 'human' nature of highly malignant heterotransplantable tumors of human origin.
Goldenberg DM; Götz H
Eur J Cancer (1965); 1968 Oct; 4(5):547-8. PubMed ID: 5760735
[No Abstract] [Full Text] [Related]
6. Immunodiagnosis in ovarian cancer: blocking factor activity.
Pattillo RA; Ruckert AC; Story MT; Mattingly RF
Am J Obstet Gynecol; 1979 Apr; 133(7):791-802. PubMed ID: 373445
[TBL] [Abstract][Full Text] [Related]
7. Tumor markers in ovarian cancer: tumor-associated antigens.
Barlow JJ; Bhattacharya M
Semin Oncol; 1975 Sep; 2(3):203-9. PubMed ID: 827023
[No Abstract] [Full Text] [Related]
8. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
Kokoschka EM
Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
[No Abstract] [Full Text] [Related]
9. [Study of humoral and cellular immunity in the course of ovarian carcinoma].
Laghi V; Carella G; Burrai I; Sacco F; Margariti PA; Villani L; Benedetti Panici P
Minerva Ginecol; 1979 Oct; 31(10):737-46. PubMed ID: 317512
[No Abstract] [Full Text] [Related]
10. [Immunity in patients with malignant ovarian neoplasms].
Markowska J; Tomaszkiewicz T; Simm S; Jankowiak S
Ginekol Pol; 1981 Aug; 52(8):729-37. PubMed ID: 6975740
[No Abstract] [Full Text] [Related]
11. Ovarian tumor antigens.
Benson MD; Lurain JR; Newton M
J Reprod Med; 1983 Jan; 28(1):17-23. PubMed ID: 6187917
[TBL] [Abstract][Full Text] [Related]
12. Leukaemia-associated antigens: a review of methods of detection and characterization.
Hyland GL
Med Lab Sci; 1978 Apr; 35(2):137-45. PubMed ID: 349301
[No Abstract] [Full Text] [Related]
13. [Distribution and diagnostic role of COTA in mucinous ovarian tumors].
Shi ZL
Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):191-2. PubMed ID: 2612330
[TBL] [Abstract][Full Text] [Related]
14. [Immunoenzyme study of interspecific embryonic antigens in the blood serum of ovarian cancer patients].
Chekhonin VP; Makarov OV; Tatarinov IuS; Griaznova IM
Akush Ginekol (Mosk); 1987 Mar; (3):69-70. PubMed ID: 3296812
[No Abstract] [Full Text] [Related]
15. Circulating antigen levels in ovarian cancer.
Colomer R; Genollà J; del Campo JM; Ruibal A
J Clin Oncol; 1986 Jul; 4(7):1148-9. PubMed ID: 3723170
[No Abstract] [Full Text] [Related]
16. [New antigens induced by herpes simplex virus in human tumors].
Posevaia TA; Grigor'ev VV; Kosiakova NP; Barinskiĭ IF
Vopr Virusol; 1981; (2):193-5. PubMed ID: 6267821
[TBL] [Abstract][Full Text] [Related]
17. [Cell-based immunology in the delayed hypersensitivity phenomena].
Del Rey Calero J
Rev Sanid Hig Publica (Madr); 1970 Dec; 44(12):1383-425. PubMed ID: 5525224
[No Abstract] [Full Text] [Related]
18. [The present status of tumor markers in malignant ovarian tumor].
Nishimura H; Miyoshi T; Hamai J; Miyahara K
Gan No Rinsho; 1985 May; 31(6 Suppl):589-93. PubMed ID: 2411960
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
Crombach G; Zippel HH; Würz H
Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
[TBL] [Abstract][Full Text] [Related]
20. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
